From Horizon Discovery
This white paper from Horizon Discovery summarizes the findings of a Foundation for the National Institutes of Health study investigating the performance of quality control materials (QCMs) in circulating tumor DNA (ctDNA) assays, demonstrating how a laboratory’s ctDNA assay workflow can be affected by the source of their QCMs.
Offered Free by: Horizon Discovery
See All Resources from: Horizon Discovery